Non-invasive Donor Liver Assessment

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Non-invasive Donor Liver Assessment trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Not Yet RecruitingNot Applicable

NCT07451379

Comparison of Liver Biopsy Versus Fibroscan With CAP ( Controlled Attenuation Parameter) in Donors Evaluation for Liver…

In our study we aiming that liver biopsy histological analysis as a reference standard, to examine the precision of fbroscan controlled attenuation parameter (C…

Location not specified100 participantsStarted 2026-07-01

CompletedNot Applicable

NCT03176290

Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation

The aim of this study is to compare prospectively the ability of MRE and Transient Elastography in detection and staging of allograft fibrosis in comparison to…

Location not specified31 participantsStarted 2014-12

Treatment: Fibro-α score = (1.35 (numeric constant) +AFP (IU ml-1) × 0.009584 + aspartate aminotransferase (AST)/alanine aminotransferase(ALT) × 0.243 - platelet count (×109 l-1) × 0.001624).